Study Details

Back
Study ID 3606-CL-3002
Study Title A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
Clinicaltrials.gov Identifier NCT00826280
Compound Name CVT3146 / regadenoson
Medical Indication or Disease Myocardial perfusion imaging
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 24-Mar-2009
Study Completion Date 15-Jul-2010
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS